Jennifer A Lewis1, Lucy B Spalluto2, Claudia I Henschke3, David F Yankelevitz3, Samuel M Aguayo4, Providencia Morales4, Rick Avila5, Carolyn M Audet6, Beth Prusaczyk7, Christopher J Lindsell8, Carol Callaway-Lane9, Robert S Dittus10, Timothy J Vogus11, Pierre P Massion12, Heather M Limper13, Sunil Kripalani14, Drew Moghanaki15, Christianne L Roumie10. 1. VA Tennessee Valley Healthcare System, Geriatric Research, Education and Clinical Center (GRECC), Nashville, TN, United States of America; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States of America; Vanderbilt Ingram Cancer Center, Nashville, TN, United States of America. Electronic address: jennifer.a.lewis@vumc.org. 2. VA Tennessee Valley Healthcare System, Geriatric Research, Education and Clinical Center (GRECC), Nashville, TN, United States of America; Vanderbilt Ingram Cancer Center, Nashville, TN, United States of America; Department of Radiology, Vanderbilt University Medical Center, Nashville, TN, United States of America. 3. Department of Radiology, Icahn School of Medicine at Mount Sinai, NY, New York, United States of America; Phoenix VA Health Care System, Phoenix, AZ, United States of America. 4. Phoenix VA Health Care System, Phoenix, AZ, United States of America. 5. Paraxial LLC, Halfmoon, NY, United States of America. 6. Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN, United States of America. 7. Division of General Medical Sciences, Washington University School of Medicine, St. Louis, MO, United States of America. 8. Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, United States of America. 9. VA Tennessee Valley Healthcare System, Geriatric Research, Education and Clinical Center (GRECC), Nashville, TN, United States of America; VA Tennessee Valley Healthcare System, Medicine Service, Nashville, TN, United States of America. 10. VA Tennessee Valley Healthcare System, Geriatric Research, Education and Clinical Center (GRECC), Nashville, TN, United States of America; Division of General Internal Medicine and Public Health, Vanderbilt University Medical Center, Nashville, TN, United States of America. 11. Owen Graduate School of Management, Vanderbilt University, Nashville, TN, United States of America. 12. Vanderbilt Ingram Cancer Center, Nashville, TN, United States of America; VA Tennessee Valley Healthcare System, Medicine Service, Nashville, TN, United States of America; Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, United States of America. 13. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States of America. 14. Division of General Internal Medicine and Public Health, Vanderbilt University Medical Center, Nashville, TN, United States of America. 15. Radiation Oncology, Atlanta VA Medical Center, Atlanta, Georgia; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.
Abstract
INTRODUCTION: The Veterans Affairs Partnership to increase Access to Lung Screening (VA-PALS) is an enterprise-wide initiative to implement lung cancer screening programs at VA medical centers (VAMCs). VA-PALS will be using implementation strategies that include program navigators to coordinate screening activities, trainings for navigators and radiologists, an open-source software management system, tools to standardize low-dose computed tomography image quality, and access to a support network. VAMCs can utilize strategies according to their local needs. In this protocol, we describe the planned program evaluation for the initial 10 VAMCs participating in VA-PALS. MATERIALS AND METHODS: The implementation of programs will be evaluated using the Consolidated Framework for Implementation Research to ensure broad contextual guidance. Program evaluation measures have been developed using the Reach, Effectiveness, Adoption, Implementation and Maintenance framework. Adaptations of screening processes will be assessed using the Framework for Reporting Adaptations and Modifications to Evidence Based Interventions. Measures collected will reflect the inner settings, estimate and describe the population reached, adoption by providers, implementation of the programs, report clinical outcomes and maintenance of programs. Analyses will include descriptive statistics and regression to evaluate predictors and assess implementation over time. DISCUSSION: This theory-based protocol will evaluate the implementation of lung cancer screening programs across the Veterans Health Administration using scientific frameworks. The findings will inform plans to expand the VA-PALS initiative beyond the original sites and can guide implementation of lung cancer screening programs more broadly. Published by Elsevier Inc.
INTRODUCTION: The Veterans Affairs Partnership to increase Access to Lung Screening (VA-PALS) is an enterprise-wide initiative to implement lung cancer screening programs at VA medical centers (VAMCs). VA-PALS will be using implementation strategies that include program navigators to coordinate screening activities, trainings for navigators and radiologists, an open-source software management system, tools to standardize low-dose computed tomography image quality, and access to a support network. VAMCs can utilize strategies according to their local needs. In this protocol, we describe the planned program evaluation for the initial 10 VAMCs participating in VA-PALS. MATERIALS AND METHODS: The implementation of programs will be evaluated using the Consolidated Framework for Implementation Research to ensure broad contextual guidance. Program evaluation measures have been developed using the Reach, Effectiveness, Adoption, Implementation and Maintenance framework. Adaptations of screening processes will be assessed using the Framework for Reporting Adaptations and Modifications to Evidence Based Interventions. Measures collected will reflect the inner settings, estimate and describe the population reached, adoption by providers, implementation of the programs, report clinical outcomes and maintenance of programs. Analyses will include descriptive statistics and regression to evaluate predictors and assess implementation over time. DISCUSSION: This theory-based protocol will evaluate the implementation of lung cancer screening programs across the Veterans Health Administration using scientific frameworks. The findings will inform plans to expand the VA-PALS initiative beyond the original sites and can guide implementation of lung cancer screening programs more broadly. Published by Elsevier Inc.
Entities:
Keywords:
Implementation science; Lung cancer screening; Program evaluation; Veterans
Authors: Carlijn Michelle van der Aalst; Karien Anna Margaretha van den Bergh; Marc Christiaan Willemsen; Henricus Johannes de Koning; Robertus Johannes van Klaveren Journal: Thorax Date: 2010-07 Impact factor: 9.139
Authors: Linda S Kinsinger; Charles Anderson; Jane Kim; Martha Larson; Stephanie H Chan; Heather A King; Kathryn L Rice; Christopher G Slatore; Nichole T Tanner; Kathleen Pittman; Robert J Monte; Rebecca B McNeil; Janet M Grubber; Michael J Kelley; Dawn Provenzale; Santanu K Datta; Nina S Sperber; Lottie K Barnes; David H Abbott; Kellie J Sims; Richard L Whitley; R Ryanne Wu; George L Jackson Journal: JAMA Intern Med Date: 2017-03-01 Impact factor: 21.873
Authors: Laura J Damschroder; David C Aron; Rosalind E Keith; Susan R Kirsh; Jeffery A Alexander; Julie C Lowery Journal: Implement Sci Date: 2009-08-07 Impact factor: 7.327
Authors: Richard Wender; Elizabeth T H Fontham; Ermilo Barrera; Graham A Colditz; Timothy R Church; David S Ettinger; Ruth Etzioni; Christopher R Flowers; G Scott Gazelle; Douglas K Kelsey; Samuel J LaMonte; James S Michaelson; Kevin C Oeffinger; Ya-Chen Tina Shih; Daniel C Sullivan; William Travis; Louise Walter; Andrew M D Wolf; Otis W Brawley; Robert A Smith Journal: CA Cancer J Clin Date: 2013-01-11 Impact factor: 508.702
Authors: Christopher M Shea; Sara R Jacobs; Denise A Esserman; Kerry Bruce; Bryan J Weiner Journal: Implement Sci Date: 2014-01-10 Impact factor: 7.327
Authors: Claudia I Henschke; Rowena Yip; Dorith Shaham; Javier J Zulueta; Samuel M Aguayo; Anthony P Reeves; Artit Jirapatnakul; Ricardo Avila; Drew Moghanaki; David F Yankelevitz Journal: J Thorac Imaging Date: 2021-01 Impact factor: 5.528
Authors: Deborah Cragun; Rita D DeBate; Susan T Vadaparampil; Julie Baldwin; Heather Hampel; Tuya Pal Journal: Genet Med Date: 2014-03-20 Impact factor: 8.822
Authors: Lucy B Spalluto; Jennifer A Lewis; Lauren R Samuels; Carol Callaway-Lane; Michael E Matheny; Jason Denton; Jennifer A Robles; Robert S Dittus; David F Yankelevitz; Claudia I Henschke; Pierre P Massion; Drew Moghanaki; Christianne L Roumie Journal: J Am Coll Radiol Date: 2022-01 Impact factor: 5.532
Authors: Thomas E Strayer; Lucy B Spalluto; Abby Burns; Christopher J Lindsell; Claudia I Henschke; David F Yankelevitz; Drew Moghanaki; Robert S Dittus; Timothy J Vogus; Carolyn Audet; Sunil Kripalani; Christianne L Roumie; Jennifer A Lewis Journal: Res Sq Date: 2022-08-08
Authors: Jennifer A Lewis; Lauren R Samuels; Jason Denton; Michael E Matheny; Amelia Maiga; Christopher G Slatore; Eric Grogan; Jane Kim; Robert H Sherrier; Robert S Dittus; Pierre P Massion; Laura Keohane; Christianne L Roumie; Sayeh Nikpay Journal: Chest Date: 2022-04-09 Impact factor: 10.262